Free Trial

PMV Pharmaceuticals (PMVP) Earnings Date, Estimates & Call Transcripts

PMV Pharmaceuticals logo
$1.45 +0.08 (+5.84%)
Closing price 04:00 PM Eastern
Extended Trading
$1.45 0.00 (0.00%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PMV Pharmaceuticals Earnings Summary

PMV Pharmaceuticals issued Q4 2025 earnings on March 6, 2026, reporting an EPS of -$0.34, which topped analysts' consensus estimates of -$0.40 by $0.06. With a trailing EPS of -$1.49, PMV Pharmaceuticals' earnings are expected to grow next year, from ($1.60) to ($1.17) per share.

Upcoming
Earnings Date
May. 8Before Market OpensEstimated
Consensus EPS
(Mar. 6)
-$0.40
Actual EPS
(Mar. 6)
-$0.34 Beat By $0.06

Q4 2025 Earnings Resources

PMVP Upcoming Earnings

PMV Pharmaceuticals' Q1 2026 earnings is estimated for Friday, May 8, 2026, based on past reporting schedules

Get PMV Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMV Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PMVP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PMV Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.38-$0.38-$0.38
Q2 20261-$0.44-$0.44-$0.44
Q3 20261-$0.43-$0.43-$0.43
Q4 20261-$0.40-$0.40-$0.40

PMV Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2026
(Estimated)
--------
3/6/2026Q4 2025-$0.40-$0.34+$0.06-$0.34--
11/12/2025Q3 2025-$0.40-$0.40--$0.40--
8/7/2025Q2 2025-$0.39-$0.41 -$0.02-$0.41--
5/9/2025Q1 2025-$0.37-$0.34+$0.03-$0.34--
3/3/2025Q4 2024-$0.37-$0.45 -$0.08-$0.45--
11/7/2024Q3 2024-$0.35-$0.37 -$0.02-$0.37--
8/8/2024--$0.34-$0.02+$0.32-$0.02--
5/9/2024Q1 2024-$0.35-$0.30+$0.05-$0.30--

Data powered by Fiscal.ai.

PMV Pharmaceuticals Earnings - Frequently Asked Questions

PMV Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 8th, 2026 based off last year's report dates. Learn more on PMVP's earnings history.

In the previous quarter, PMV Pharmaceuticals (NASDAQ:PMVP) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.06. Learn more on analysts' earnings estimate vs. PMVP's actual earnings.

PMV Pharmaceuticals (NASDAQ:PMVP) has a recorded net income of -$77.74 million. PMVP has generated -$1.49 earnings per share over the last four quarters.

PMV Pharmaceuticals' earnings are expected to grow from ($1.60) per share to ($1.17) per share in the next year.


This page (NASDAQ:PMVP) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners